InsidersTradesSigma
Track the HUTCHMED (China) Ltd. stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. The latest transaction was filed on 22 May 2026 (Purchase). Among the most active insiders: CHENG Chig Fung Johnny. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
HUTCHMED (China) Ltd. is a biopharmaceutical company focused on the research and development of drugs for cancer treatment and immune-related diseases. It is based in China and also operates internationally.